Prof. François Mach (h index >100), is an expert in the field of development and progression of atherosclerosis diseases. He obtained his MD in internal medicine and cardiology at the University of Geneva. He completed a post-doctoral fellowship in the laboratory of Prof. Peter Libby, Boston (1995-1999). He became full Professor of cardiology in 2000, and was appointed Head of the cardiology department at Geneva University Hospital in 2002. Between 2012-14, he was the President of the Swiss Society of Cardiology. He is the author of more than 500 high impact factor publications and responsible of several Swiss cohorts of atherothrombotic patients, strongly implicated in clinical research in the field of prevention, especially lipidology. He was one of the 3 co-chairs of the ESC 2019 Lipid Guidelines, and co-chaired the ESC 2021 Prevention Guidelines. He is currently co-chairing the 2025 ESC/EAS Focus Lipid guidelines.
